PlainRecalls
FDA Drug Moderate Class II Terminated

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02

Reported: January 6, 2021 Initiated: December 17, 2020 #D-0184-2021

Product Description

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02

Reason for Recall

Presence of Particulate Matter - found in reserve sample vials at the firm.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
490,633 vials
Distribution
USA Nationwide and Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02. Recalled by Fresenius Kabi USA, LLC. Units affected: 490,633 vials.
Why was this product recalled?
Presence of Particulate Matter - found in reserve sample vials at the firm.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 6, 2021. Severity: Moderate. Recall number: D-0184-2021.